Metraipolis › archive › dc_a8ee60749305

The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease — Europe PMC PMID:41479572

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41479572
DOI
10.32607/actanaturae.27808
License (as archived)
solo-consultazione
Archived
2026-11-09T15:46:49.414Z
SHA-256 of the archived text
e260c1dabb6e727d91bbaf36441d14c6fee0f7414159a1ebda7248e161d01501
Stable URL of this page
https://metraipolis.com/documento/dc_a8ee60749305

How to cite

The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease — Europe PMC PMID:41479572 — Europe PMC (en), https://europepmc.org/article/MED/41479572 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a8ee60749305 (Metraipolis archive dc_a8ee60749305, sha256 e260c1dabb6e727d91bbaf36441d14c6fee0f7414159a1ebda7248e161d01501)
BibTeX
@misc{dca8ee60749305,
  title = {The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease — Europe PMC PMID:41479572},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41479572},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a8ee60749305; sha256 e260c1dabb6e727d91bbaf36441d14c6fee0f7414159a1ebda7248e161d01501},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41479572. Agents can read the archived copy with the MCP tool read_document.